Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000893404) titled 'FareShare Medically Tailored Meals Pilot Program for Type 2 Diabetes' on Aug. 18.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: The George Institute of Global Health
Condition:
Type 2 Diabetes
Type 2 Diabetes
Metabolic and Endocrine - Diabetes
Intervention:
Within the scope of this jointly led community-based, non-randomised clinical pilot feasibility study, the 12-week medically tailored meals intervention comprises weekly direct delivery of ready-m...